When was Evogene founded?

Evogene was founded in 2002 and raised its 1st funding round 6 years after it was founded.

Where is Evogene located?

Evogene is headquartered in Rehovot, Israel. It is registered at 13, גד פינשטיין, רחובות.

How many employees does Evogene have?

As of Sep 30, 2026, the latest employee count at Evogene is 98.

Is Evogene a funded company?

Evogene is a funded company, having raised an undisclosed amount across 4 funding rounds to date. The company's 1st funding round was a $***** Post IPO round, raised on Apr 30, 2008.

When was the latest funding round of Evogene?

Evogene's latest funding was a $***** Grant (prize money) round on May 09, 2023, with participation from 0 investor. Its primary sector is Crop Tech. In Israel, the Crop Tech sector has seen $29.8M in funding in 2026 to date.

What is the annual revenue of Evogene?

Annual revenue of Evogene is between $1M and $10M as on Dec 31, 2024

Where does Evogene rank among its competitors?

Evogene ranks 13th amongst 319 active competitors, of which 85 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Computomics, which secured $7.3M in Aug, 2026.

Who are the top competitors of Evogene?

Evogene's top competitors include Advanta, Tropic Biosciences and Computomics. Among them, Computomics secured the most recent funding round in August, 2026.

Evogene - 2026 Company Profile, Funding, Competitors & Financials

Company Details

Developer of computational tools for pharmaceutical and agricultural industries. The company utilizes generative artificial intelligence to design small molecules optimized for multiple parameters. These molecules increase the probability of success while reducing time and costs. The business facilitates the development of market-ready products for drug discovery and agricultural chemicals through strategic partnerships and in-house expertise.

Website: evogene.com
Social
Email ID: *****@evogene.com
Phone Number: +972 **********
Registered Address: 13, גד פינשטיין, רחובות

Key Metrics

Founded Year

2002

Location

Rehovot, Israel

Stage

Public

Latest Funding Round

Grant (prize money), May 09, 2023, $*****

Investors

Shavit Capital & 5 more

Ranked

13^th among 319 active competitors

Annual Revenue

$1M - $10M as on Dec 31, 2024

Employee Count

98 as on Sep 30, 2026

Similar Companies

Advanta & 360 more

Exit Details

Public

View Evogene's full profile

Evogene is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Evogen Ltd. CIN: 512838723 , Israel, Active	Oct 10, 1999	$1M - $10M (As on Dec 31, 2024)	-	-

Evogene got listed on Mar 17, 2008.

Click here to take a look at Evogene's IPO in detail

Evogene has raised funding over 4 rounds. Its first funding round was on Apr 30, 2008. Evogene has 6 institutional investors.

Here is the list of recent funding rounds of Evogene:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 09, 2023	4092053	Grant (prize money)	7256676	4472219	7154234	2815388
May 01, 2023	1698833	Grant (prize money)	9891165	4648493	8196617	Europa
Jan 01, 2016	2917510	Grant (prize money)	1507403	7676134	3970098	Europa

Access funding benchmarks and valuations. Sign up today!

View details of Evogene's funding rounds and investors

Evogene's employee count trend

Evogene has 98 employees as of Sep 26. Here is Evogene's employee count trend over the years:

Uncover Evogene's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Evogene include Advanta, Tropic Biosciences and Computomics. Here is the list of Top 10 competitors of Evogene, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Advanta 1989, Dubai (United Arab Emirates), Public	Developer of high-nutrition crops for sustainable agriculture	$400M	KKR, Alpha Wave Global & 5 others	74/100
2nd	Tropic Biosciences 2016, Norwich (United Kingdom), Series C	Developer of gene editing technologies for improved tropical crop production	$179M	Temasek, Aliment Capital & 39 others	68/100
3rd	Computomics 2012, Tubingen (Germany), Series B	Provider of data analysis services for next-generation sequencing data for the crop science industry	$7.85M	BASF, Convent Capital & 8 others	61/100
4th	Phylos Bioscience 2014, Portland (United States), Series B	Developer of cannabis F1 hybrid seeds and natural THC products	$31.2M	Merida Capital Partners, Entourage Effect Capital ... & 6 others	60/100
5th	Ohalo 2019, Aptos (United States), Series C	Developer of plant breeding systems for potatoes, almonds, and strawberries	$40M	Craft Ventures, Khosla Ventures	58/100
6th	Biographica 2022, London (United Kingdom), Seed	Computational Platform for gene discovery and editing	$9.5M	Faber, Entrepreneurs First & 4 others	57/100
7th	Cibus 2001, San Diego (United States), Public	Developer of precision breeding technologies for resilient and vigorous crops	$34.5M	Fidelity Investments, Qubis & 7 others	57/100
8th	Plastomics 2016, St. Louis (United States), Series B	Developer of next-generation trait delivery technology for higher-yielding crops and sustainable agriculture	$18.5M	Lewis & Clark Agrifood, BioGenerator & 21 others	57/100
9th	Avalo 2020, Durham (United States), Series A	Developer of a platform for accelerated crop breeding and evolution	$11.3M	Climate Capital, IndieBio & 12 others	56/100
10th	Medicinal Genomics 2011, Beverly (United States), Acquired	Provider of microbial and plant pathogen testing for multiple industries	$7.69M	First Analysis, Bunker Hill Capital & 1 others	56/100
13th	Evogene 2002, Rehovot (Israel), Public	Developer of computational tools for pharmaceutical and agricultural industries	-	Shavit Capital, GlenRock Israel & 4 others	55/100